Japan Technology Journal
SEE OTHER BRANDS

The best science and technology news from Japan

Japan Technology Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Japan Technology Journal.

Press releases published on June 12, 2025

Key Trend in Video Editing Software Global Market: Advancements In AI-Powered Video Editing Tools Enhancing Speed

Key Trend in Video Editing Software Global Market: Advancements In AI-Powered Video Editing Tools Enhancing Speed

The Business Research Company’s Video Editing Software Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 12, 2025 /⁨EINPresswire.com⁩/ -- It's evident that the world of video editing …

Global Electronic Access Control Market Set For 14.4% Growth, Reaching $25.51 Billion By 2029

Global Electronic Access Control Market Set For 14.4% Growth, Reaching $25.51 Billion By 2029

The Business Research Company's Electronic Access Control Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 12, 2025 /⁨EINPresswire.com⁩/ -- Growth of the electronic access control …

ROHM Builds the Future of AI with Optimized Solutions for NVIDIA 800V Architecture

ROHM Builds the Future of AI with Optimized Solutions for NVIDIA 800V Architecture

Santa Clara, CA, June 12, 2025 (GLOBE NEWSWIRE) -- As artificial intelligence continues to redefine the boundaries of computing, the infrastructure powering these advancements must evolve in parallel. A recognized leader in power semiconductor technology, …

Kura Oncology and Kyowa Kirin Report Positive Updated Combination Data for Ziftomenib in Newly Diagnosed AML at 2025 European Hematology Association Congress

Kura Oncology and Kyowa Kirin Report Positive Updated Combination Data for Ziftomenib in Newly Diagnosed AML at 2025 European Hematology Association Congress

– Encouraging clinical activity with deep responses demonstrated in the KOMET-007 trial with the combination of 600 mg ziftomenib with 7+3 in newly diagnosed patients with NPM1-m and KMT2A-r AML – – 93% (41/44) and 89% (24/27) CRc observed in NPM1-m and …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service